Nunn, Andrew

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 827

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack, S., Ramjee, G., Kamali, A., Rees, H., Crook, A. M., Gafos, M., Jentsch, U., Pool, R., Chisembele, M., Kapiga, S., et al. (2010) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 335

Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial

McMillan, A., Bratton, D. J., Faria, R., Laskawiec-Szkonter, M., Griffin, S., Davies, R. J., Nunn, A. J., Stradling, J. R., Riha, R. L., & Morrell, M. J. (2014) · The Lancet Respiratory Medicine

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 234

Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial

Craig, S. E., Kohler, M., Nicoll, D., Bratton, D. J., Nunn, A., Davies, R., & Stradling, J. (2012) · Thorax

Obstructive Sleep Apnea ResearchSleep and related disorders

Cited by 228